Checchi Capital Advisers LLC Has $1.13 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Checchi Capital Advisers LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS – Get Rating) by 4.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,172 shares of the pharmacy operator’s stock after selling 620 shares during the period. Checchi Capital Advisers LLC’s holdings in CVS Health were worth $1,134,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Hall Capital Management Co. Inc. increased its holdings in shares of CVS Health by 12.8% during the 4th quarter. Hall Capital Management Co. Inc. now owns 6,803 shares of the pharmacy operator’s stock worth $634,000 after purchasing an additional 774 shares during the period. Ipsen Advisor Group LLC bought a new position in shares of CVS Health during the 4th quarter worth about $476,000. Globeflex Capital L P raised its holdings in shares of CVS Health by 111.9% in the 4th quarter. Globeflex Capital L P now owns 242,381 shares of the pharmacy operator’s stock worth $22,587,000 after buying an additional 128,000 shares in the last quarter. Wealth Quarterback LLC raised its holdings in shares of CVS Health by 1.2% in the 4th quarter. Wealth Quarterback LLC now owns 10,015 shares of the pharmacy operator’s stock worth $933,000 after buying an additional 119 shares in the last quarter. Finally, SYSTM Wealth Solutions LLC acquired a new position in shares of CVS Health in the 4th quarter worth approximately $5,869,000. 77.29% of the stock is currently owned by institutional investors.

Insider Transactions at CVS Health

In other CVS Health news, CEO Karen S. Lynch bought 14,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 3rd. The shares were bought at an average price of $69.75 per share, for a total transaction of $976,500.00. Following the transaction, the chief executive officer now directly owns 431,392 shares in the company, valued at $30,089,592. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.25% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Bank of America reduced their target price on CVS Health from $111.00 to $104.00 and set a “buy” rating on the stock in a report on Friday, March 31st. Barclays lowered their price target on shares of CVS Health from $100.00 to $90.00 in a report on Thursday, May 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $115.00 price target on shares of CVS Health in a report on Thursday, February 9th. Truist Financial dropped their target price on shares of CVS Health from $115.00 to $109.00 in a research report on Thursday, May 4th. Finally, 92 Resources reaffirmed a “maintains” rating on shares of CVS Health in a research note on Monday, May 8th. Three analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $108.75.

CVS Health Price Performance

Shares of CVS stock traded down $0.17 during trading hours on Friday, reaching $67.50. The company’s stock had a trading volume of 1,186,817 shares, compared to its average volume of 8,887,342. The company has a market capitalization of $86.54 billion, a price-to-earnings ratio of 22.44, a PEG ratio of 1.25 and a beta of 0.61. The company has a quick ratio of 0.67, a current ratio of 0.92 and a debt-to-equity ratio of 0.79. CVS Health Co. has a fifty-two week low of $66.61 and a fifty-two week high of $107.26. The firm’s 50 day simple moving average is $72.74 and its 200-day simple moving average is $84.92.

CVS Health (NYSE:CVS – Get Rating) last released its quarterly earnings results on Wednesday, May 3rd. The pharmacy operator reported $2.20 earnings per share for the quarter, topping the consensus estimate of $2.07 by $0.13. The company had revenue of $85.28 billion for the quarter, compared to analysts’ expectations of $80.67 billion. CVS Health had a return on equity of 15.75% and a net margin of 1.20%. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $2.22 earnings per share. Sell-side analysts forecast that CVS Health Co. will post 8.63 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, May 1st. Stockholders of record on Friday, April 21st were given a dividend of $0.605 per share. This represents a $2.42 annualized dividend and a dividend yield of 3.59%. The ex-dividend date was Thursday, April 20th. CVS Health’s dividend payout ratio (DPR) is presently 79.87%.

About CVS Health

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.